A novel mutation in the PSEN2 gene, Thr421Met, was identified in a 57-year-old patient with early-onset Alzheimer's disease. This mutation was previously unknown in Korea, highlighting the importance of genetic screening in patients with EOAD. The discovery of this mutation underscores the need for further research into the genetic underpinnings of Alzheimer's disease, particularly in the Korean population.